Cellular senescence

Cellular senescence is a state in which a cell permanently stops dividing but does not die, remaining in the tissue and releasing a mix of inflammatory signals. Popular writing calls these “zombie cells”, and the nickname is fair: they are metabolically active, resistant to normal cell death, and they change the behavior of healthy neighbors. Senescence is useful in the short term, because it stops a damaged cell from becoming a tumor and it helps wounds close, but the cells are supposed to be cleared afterward. With age, clearance slows and they accumulate. The reference entry on Cellular senescence covers the same ground in more depth.

What it measures

Senescence is a cell state, not a number on a lab report. When a cell sustains damage it cannot repair, it has three broad options: repair and carry on, self-destruct by Apoptosis, or shut down division and enter senescence. The senescent cell then grows flat and enlarged, switches on the cell-cycle brakes p16INK4a and p21, and starts producing what researchers call the senescence-associated secretory phenotype, or SASP — cytokines such as IL-6 and IL-8, chemokines, growth factors and enzymes that remodel the surrounding tissue.

There is no single definitive marker and no validated clinical test. Laboratories identify senescent cells with a panel: senescence-associated beta-galactosidase staining, raised p16 or p21, loss of the nuclear protein lamin B1, absence of proliferation markers, and evidence of SASP secretion. Each of these appears in non-senescent cells too, which is why any one of them alone is considered weak evidence. Blood-based SASP panels and p16 expression in immune cells are used in research, but no consumer test can tell you your senescent cell burden.

Why it matters for longevity

Senescence is on every published list of the hallmarks of aging, and it is one of the few where animal evidence is genuinely causal rather than associative. In genetically engineered mice that allow p16-positive cells to be killed on demand, removing those cells delays the onset of age-related disease in several organs, improves function, and extends median lifespan. Running the experiment in reverse works too: transplanting a modest number of senescent cells into a young mouse produces measurable physical dysfunction.

The link to human aging is more indirect. Senescent cells are found in higher numbers in aged and diseased human tissue — arteries, joints, kidney, lung, fat — and their SASP output is one of the proposed sources of the chronic low-grade inflammation of aging. Human trials of senolytics, the drugs designed to clear these cells, are small, short and early: some report a reduction in senescent cell markers or a functional signal in specific diseases, none has shown that clearing them slows aging or extends life in people.

What changes it

The main triggers are forms of damage. Repeated division erodes Telomeres until the chromosome ends register as broken DNA, which produces replicative senescence; oncogene activation, oxidative stress, mitochondrial dysfunction, chronic high glucose, ultraviolet light, smoking, radiation and chemotherapy all drive the same state through DNA damage. A declining immune system matters as much as the trigger, because senescent cells are normally removed by natural killer cells and macrophages, and that surveillance weakens with age.

What you control is mostly upstream. Not smoking, using sun protection, keeping blood glucose and body fat in a healthy range, and training regularly are all associated with lower levels of senescence markers in human tissue, although the studies are observational and the markers are imperfect. Senolytic compounds — dasatinib with quercetin, and fisetin — are the most-discussed intervention and remain experimental; dasatinib is a prescription cancer drug with real toxicity, and self-dosing outside a trial is not a reasonable bet on evidence this thin.

Related reading


Disclaimer. This article is for information only and does not replace medical advice. Talk to a qualified clinician before changing anything about your health.